Strategies for implementing lipid-lowering therapy: pharmacy-based approach (Q73495292)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Strategies for implementing lipid-lowering therapy: pharmacy-based approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

K K Birtcher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Bowden

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C M Ballantyne

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Huyen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

30A-35A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900936-4

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900936-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900936-4

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900936-4

Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900936-4

10.1016/S0002-9149(99)00936-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695705%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference